Skip to main content
PMC home page
Bacteriological Reviews logoLink to Bacteriological Reviews
. 1967 Mar;31(1):35–53. doi: 10.1128/br.31.1.35-53.1967

Experimentally induced immunity in the mycoses.

Y C Kong, H B Levine
PMCID: PMC441021  PMID: 4962952

Full text

PDF
39

Images in this article

36Image
on p.36
46Image
on p.46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahams I. Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis. J Immunol. 1966 Mar;96(3):525–529. [PubMed] [Google Scholar]
  2. BARCLAY W. R., WINBERG E. Histoplasmosis. In vivo observations on immunity, hypersensitivity, and the effects of silica and amphotericin B. Am Rev Respir Dis. 1963 Mar;87:331–337. doi: 10.1164/arrd.1963.87.3P1.331. [DOI] [PubMed] [Google Scholar]
  3. BENNETT J. E., HASENCLEVER H. F., BAUM G. L. EVALUATION OF A SKIN TEST FOR CRYPTOCOCCOSIS. Am Rev Respir Dis. 1965 Apr;91:616–616. doi: 10.1164/arrd.1965.91.4.616. [DOI] [PubMed] [Google Scholar]
  4. BLANK F., BURKE R. C. Chemical composition of the cell wall of Coccidioides immitis. Nature. 1954 May 1;173(4409):829–829. doi: 10.1038/173829a0. [DOI] [PubMed] [Google Scholar]
  5. BLANK F. On the cell walls of dimorphic fungi causing systemic infections. Can J Microbiol. 1954 Aug;1(1):1–5. doi: 10.1139/m55-001. [DOI] [PubMed] [Google Scholar]
  6. BOX E. D., BRIGGS N. T. Endotoxin susceptibility and delayed hypersensitivity in experimental histoplasmosis. J Immunol. 1961 Oct;87:485–491. [PubMed] [Google Scholar]
  7. BROSBE E. A., KIETZMAN J. N., KURNICK N. B. COMPLEMENT-FIXATION TITERS IN EXPERIMENTAL COCCIDIOIDOMYCOSIS IN RABBITS. J Bacteriol. 1964 Jul;88:233–241. doi: 10.1128/jb.88.1.233-241.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CONVERSE J. L., CASTLEBERRY M. W., BESEMER A. R., SNYDER E. M. Immunization of mice against coccidioidomycosis. J Bacteriol. 1962 Jul;84:46–52. doi: 10.1128/jb.84.1.46-52.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. CONVERSE J. L., CASTLEBERRY M. W., SNYDER E. M. EXPERIMENTAL VIABLE VACCINE AGAINST PULMONARY COCCIDIOIDOMYCOSIS IN MONKEYS. J Bacteriol. 1963 Nov;86:1041–1051. doi: 10.1128/jb.86.5.1041-1051.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. CONVERSE J. L., LOWE E. P., CASTLEBERRY M. W., BLUNDELL G. P., BESEMER A. R. Pathogenesis of Coccidioides immitis in monkeys. J Bacteriol. 1962 Apr;83:871–878. doi: 10.1128/jb.83.4.871-878.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. CONVERSE J. L., PAKES S. P., SNYDER E. M., CASTLEBERRY M. W. EXPERIMENTAL PRIMARY CUTANEOUS COCCIDIOIDOMYCOSIS IN THE MONKEY. J Bacteriol. 1964 Jan;87:81–85. doi: 10.1128/jb.87.1.81-85.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Castleberry M. W., Converse J. L., Soto P. J., Jr Antibiotic control of tissue reactions in dogs vaccinated with viable cells of Coccidioides immitis. J Bacteriol. 1964 May;87(5):1216–1220. doi: 10.1128/jb.87.5.1216-1220.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Converse J. L., Deauville G. A., Snyder E. M., Ray J. G., Seaquist M. E. Control of Tissue Reactions in Monkeys Vaccinated with Viable Coccidioides immitis by Prevaccination with Killed Coccidioides immitis. J Bacteriol. 1965 Sep;90(3):783–788. doi: 10.1128/jb.90.3.783-788.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. DAY R. Experimental ocular histoplasmosis. Am J Ophthalmol. 1949 Oct;32(10):1317–1330. doi: 10.1016/s0002-9394(49)91750-x. [DOI] [PubMed] [Google Scholar]
  15. DYSON J. E., Jr, EVANS E. E. Delayed hypersensitivity in experimental fungus infections: the skin reactivity of antigens from the yeast phase of Blastomyces dermatitidis. J Invest Dermatol. 1955 Apr;24(4):447–454. doi: 10.1038/jid.1955.60. [DOI] [PubMed] [Google Scholar]
  16. EVANS E. E., KESSEL J. F. The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharide. J Immunol. 1951 Aug;67(2):109–114. [PubMed] [Google Scholar]
  17. EVANS E. E., SORENSEN L. J., WALLS K. W. The antigenic composition of Cryptococcus neoformans. V. A survey of cross-reactions among strains of Cryptococcus and other antigens. J Bacteriol. 1953 Sep;66(3):287–293. doi: 10.1128/jb.66.3.287-293.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. EVANS E. E. The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J Immunol. 1950 May;64(5):423–430. [PubMed] [Google Scholar]
  19. FARRELL R. L., COLE C. R., PRIOR J. A., SASLAW S. Experimental histoplasmosis, I. Methods for production of histoplasmosis in dogs. Proc Soc Exp Biol Med. 1953 Oct;84(1):51–54. doi: 10.3181/00379727-84-20538. [DOI] [PubMed] [Google Scholar]
  20. FAZEKAS G., SCHWARZ J. Histology of experimental murine cryptococcosis. Am J Pathol. 1958 May-Jun;34(3):517–529. [PMC free article] [PubMed] [Google Scholar]
  21. FOLEY J. M., BERMAN R. J., SMITH C. E. X-ray irradiation of Coccidioides immitis arthrospores: survival curves and avirulent mutants isolated. J Bacteriol. 1960 Apr;79:480–487. doi: 10.1128/jb.79.4.480-487.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. FRIEDMAN L., CONANT N. F. Immunologic studies on the etiologic agents of North and South American blastomycosis. I. Comparison of hypersensitivity reactions. Mycopathol Mycol Appl. 1953 Oct 31;6(4):310–316. doi: 10.1007/BF02056713. [DOI] [PubMed] [Google Scholar]
  23. FRIEDMAN L., SMITH C. E., GORDON L. E. The assay of virulence of Coccidioides in white mice. J Infect Dis. 1955 Nov-Dec;97(3):311–316. doi: 10.1093/infdis/97.3.311. [DOI] [PubMed] [Google Scholar]
  24. FRIEDMAN L., SMITH C. E. Vaccination of mice against Coccidoides immitis. Am Rev Tuberc. 1956 Aug;74(2 Pt 1):245–248. doi: 10.1164/artpd.1956.74.2-1.245. [DOI] [PubMed] [Google Scholar]
  25. GADEBUSCH H. H. Active immunization against Cryptococcus neoformans. J Infect Dis. 1958 May-Jun;102(3):219–226. doi: 10.1093/infdis/102.3.219. [DOI] [PubMed] [Google Scholar]
  26. GADEBUSCH H. H., GIKAS P. W. Natural host resistance to infection with Cryptococcus neoformans. II. The influence of thiamine on experimental infection in mice. J Infect Dis. 1963 Mar-Apr;112:125–133. doi: 10.1093/infdis/112.2.125. [DOI] [PubMed] [Google Scholar]
  27. GADEBUSCH H. H. IMMUNIZATION AGAINST CRYPTOCOCCUS NEOFORMANS BY CAPSULAR POLYSACCHARIDE. Nature. 1963 Aug 17;199:710–710. doi: 10.1038/199710a0. [DOI] [PubMed] [Google Scholar]
  28. GADEBUSCH H. H. Passive immunization against Cryptococcus neoformans. Proc Soc Exp Biol Med. 1958 Jul;98(3):611–614. doi: 10.3181/00379727-98-24123. [DOI] [PubMed] [Google Scholar]
  29. GADEBUSCH H. H. Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. III. Antibody stimulation by partially decapsulated cells. J Infect Dis. 1960 Nov-Dec;107:406–409. doi: 10.1093/infdis/107.3.406. [DOI] [PubMed] [Google Scholar]
  30. GADEBUSCH H. H., WARD P. A., FRENKEL E. P. NATURAL HOST RESISTANCE TO INFECTION WITH CRYPTOCOCCUS NEOFORMANS. III. THE EFFECT OF CRYPTOCOCCAL POLYSACCHARIDE UPON THE PHYSIOLOGY OF THE RETICULOENDOTHELIAL SYSTEM OF LABORATORY ANIMALS. J Infect Dis. 1964 Feb;114:95–106. doi: 10.1093/infdis/114.1.95. [DOI] [PubMed] [Google Scholar]
  31. GRAYSTON J. T., SALVIN S. B. Experimental histoplasmosis in immunized and nonimmunized mice; comparative pathology. AMA Arch Pathol. 1956 May;61(5):422–433. [PubMed] [Google Scholar]
  32. HASENCLEVER H. F., MITCHELL W. O. ACQUIRED IMMUNITY TO CANDIDIASIS IN MICE. J Bacteriol. 1963 Sep;86:401–406. doi: 10.1128/jb.86.3.401-406.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. HASENCLEVER H. F., MITCHELL W. O. Virulence and growth rates of Cryptococcus neoformans in mice. Ann N Y Acad Sci. 1960 Aug 27;89:156–162. doi: 10.1111/j.1749-6632.1960.tb20138.x. [DOI] [PubMed] [Google Scholar]
  34. HEDGECOCK L. W. Effect of vaccines prepared from Histoplasma capsulatum and other yeasts on experimental tuberculosis. J Bacteriol. 1961 Jul;82:115–123. doi: 10.1128/jb.82.1.115-123.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. HILL G. A., MARCUS S. Challenge of Macacus irus with Histoplasma capsulatum. Am Rev Tuberc. 1957 May;75(5):849–851. doi: 10.1164/artpd.1957.75.5.849. [DOI] [PubMed] [Google Scholar]
  36. HILL G. A., MARCUS S. Resistance induced against Histoplasma capsulatum; quantitative aspects. J Infect Dis. 1959 Jul-Aug;105(1):26–30. doi: 10.1093/infdis/105.1.26. [DOI] [PubMed] [Google Scholar]
  37. HOWARD D. H. INTRACELLULAR GROWTH OF HISTOPLASMA CAPSULATUM. J Bacteriol. 1965 Feb;89:518–523. doi: 10.1128/jb.89.2.518-523.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. JOHNSON R. W., SCHERAGO M. The effect of histoplasmin in vitro on the migration of leukocytes from guinea pigs experimentally infected with Histoplasma capsulatum. Am Rev Respir Dis. 1960 Jan;81:96–99. doi: 10.1164/arrd.1960.81.1.96. [DOI] [PubMed] [Google Scholar]
  39. KAPLAN W., CLIFFORD M. K. PRODUCTION OF FLUORESCENT ANTIBODY REAGENTS SPECIFIC FOR THE TISSUE FORM OF COCCIDIOIDES IMMITIS. Am Rev Respir Dis. 1964 May;89:651–658. doi: 10.1164/arrd.1964.89.5.651. [DOI] [PubMed] [Google Scholar]
  40. KASE A., METZGER J. F. Isolation of a dry variant from a mucoid strain of Cryptococcus neoformas and preliminary comparative studies. J Bacteriol. 1962 Apr;83:926–928. doi: 10.1128/jb.83.4.926-928.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. KAUFMAN L., KAPLAN W. SEROLOGICAL CHARACTERIZATION OF PATHOGENIC FUNGI BY MEANS OF FLUORESCENT ANTIBODIES. I. ANTIGENIC RELATIONSHIPS BETWEEN YEAST AND MYCELIAL FORMS OF HISTOPLASMA CAPSULATUM AND BLASTOMYCES DERMATITIDIS. J Bacteriol. 1963 May;85:986–991. doi: 10.1128/jb.85.5.986-991.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. KNIGHT R. A., HILL G., MARCUS S. Immunization of mice with polysaccharides of Histoplasma capsulatum. Proc Soc Exp Biol Med. 1959 Feb;100(2):356–358. doi: 10.3181/00379727-100-24625. [DOI] [PubMed] [Google Scholar]
  43. KNIGHT R. A., MARCUS S. Polysaccharide skin test antigens derived from Histoplasma capsulatum and Blastomyces dermatitidis. Am Rev Tuberc. 1958 Jun;77(6):983–989. doi: 10.1164/artpd.1958.77.6.983. [DOI] [PubMed] [Google Scholar]
  44. KONG Y. C., LEVINE H. B., MADIN S. H., SMITH C. E. FUNGAL MULTIPLICATION AND HISTOPATHOLOGIC CHANGES IN VACCINATED MICE INFECTED WITH COCCIDIOIDES IMMITIS. J Immunol. 1964 May;92:779–790. [PubMed] [Google Scholar]
  45. KONG Y. C., LEVINE H. B., SMITH C. E. Immunogenic properties of nondisrupted and disrupted spherules of Coccidioides immitis in mice. Sabouraudia. 1963 Feb;2:131–142. [PubMed] [Google Scholar]
  46. Kong Y. C., Savage D. C., Kong L. N. Delayed dermal hypersensitivity in mice to spherule and mycelial extracts of Coccidioides immitis. J Bacteriol. 1966 Feb;91(2):876–883. doi: 10.1128/jb.91.2.876-883.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Kong Y. M., Savage D. C., Levine H. B. Enhancement of immune responses in mice by a booster injection of Coccidioides spherules. J Immunol. 1965 Dec;95(6):1048–1056. [PubMed] [Google Scholar]
  48. LEVINE H. B., COBB J. M., SMITH C. E. Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines. Trans N Y Acad Sci. 1960 Apr;22:436–449. doi: 10.1111/j.2164-0947.1960.tb00711.x. [DOI] [PubMed] [Google Scholar]
  49. LEVINE H. B., COBB J. M., SMITH C. E. Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice. J Immunol. 1961 Aug;87:218–227. [PubMed] [Google Scholar]
  50. LEVINE H. B., KONG Y. C., SMITH C. IMMUNIZATION OF MICE TO COCCIDIOIDES IMMITIS: DOSE, REGIMEN AND SPHERULATION STAGE OF KILLED SPHERULE VACCINES. J Immunol. 1965 Jan;94:132–142. [PubMed] [Google Scholar]
  51. LEVINE H. B., MILLER R. L., SMITH C. E. Influence of vaccination on respiratory coccidiodial disease in cynomolgous monkeys. J Immunol. 1962 Aug;89:242–251. [PubMed] [Google Scholar]
  52. LEVINE S., ZIMMERMAN H. M., SCORZA A. Experimental cryptococcosis (torulosis). Am J Pathol. 1957 May-Jun;33(3):385–409. [PMC free article] [PubMed] [Google Scholar]
  53. LOMANITZ R., HALE J. M. PRODUCTION OF DELAYED HYPERSENSITIVITY TO CRYPTOCOCCUS NEOFORMANS IN EXPERIMENTAL ANIMALS. J Bacteriol. 1963 Sep;86:505–509. doi: 10.1128/jb.86.3.505-509.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. LOURIA D. B. Specific and non-specific immunity in experimental cryptococcosis in mice. J Exp Med. 1960 May 1;111:643–665. doi: 10.1084/jem.111.5.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. LUTSKY I., BRODISH J. EXPERIMENTAL CANINE CRYPTOCOCCOSIS. J Infect Dis. 1964 Jun;114:273–276. doi: 10.1093/infdis/114.3.273. [DOI] [PubMed] [Google Scholar]
  56. Larsh H. W., Cozad G. C. Respiratory infection of mice with Histoplasma capsulatum. Mycopathol Mycol Appl. 1965 Dec 1;27(3):305–310. doi: 10.1007/BF02053788. [DOI] [PubMed] [Google Scholar]
  57. Levine H. B., Kong Y. C. Immunologic impairment in mice treated intravenously with killed Coccidioides immitis spherules: suppressed response to intramuscular doses. J Immunol. 1966 Sep;97(3):297–305. [PubMed] [Google Scholar]
  58. Levine H. B., Kong Y. M. Immunity development in mice RECEIVING KILLED Coccidioides immitis spherules: effect of removing residual vaccine. Sabouraudia. 1965 Oct;4(3):164–170. [PubMed] [Google Scholar]
  59. Louria D. B., Kaminski T. Passively-acquired immunity in experimental cryptococcosis. Sabouraudia. 1965 Jun;4(2):80–84. doi: 10.1080/00362176685190211. [DOI] [PubMed] [Google Scholar]
  60. MARKOWITZ H. POLYSACCHARIDE ANTIGENS FROM HISTOPLASMA CAPSULATUM. Proc Soc Exp Biol Med. 1964 Mar;115:697–700. doi: 10.3181/00379727-115-29010. [DOI] [PubMed] [Google Scholar]
  61. MARTIN D. S. Serologic studies on North American blastomycosis; studies with soluble antigens from untreated and sonic-treated yeast-phase cells of Blastomyces dermatitidis. J Immunol. 1953 Oct;71(4):192–201. [PubMed] [Google Scholar]
  62. MIYA F., MARCUS S. Effect of humoral factors in vitro phagocytic and cytopeptic activities of normal and "immune" phagocytes. J Immunol. 1961 Jun;86:652–668. [PubMed] [Google Scholar]
  63. NEILL J. M., ABRAHAMS I., KAPROS C. E. A comparison of the immunogenicity of weakly encapsulated and of strongly encapsulated strains of Cryptococcus neoformans (Torula histolytica). J Bacteriol. 1950 Feb;59(2):263–275. doi: 10.1128/jb.59.2.263-275.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. PAPPAGIANIS D., KOBAYASHI G. S. Approaches to the physiology of Coccidioides immitis. Ann N Y Acad Sci. 1960 Aug 27;89:109–121. doi: 10.1111/j.1749-6632.1960.tb20135.x. [DOI] [PubMed] [Google Scholar]
  65. PAPPAGIANIS D., LEVINE H. B., SMITH C. E., BERMAN R. J., KOBAYASHI G. S. Immunization of mice with viable Cocidioides immitis. J Immunol. 1961 Jan;86:28–34. [PubMed] [Google Scholar]
  66. PAPPAGIANIS D., MILLER R. L., SMITH C. E., KOBAYASHI G. S. Response of monkeys to respiratory challenge following subcutaneous inoculation with Coccidioides immitis. Am Rev Respir Dis. 1960 Aug;82:244–250. doi: 10.1164/arrd.1960.82.2.244. [DOI] [PubMed] [Google Scholar]
  67. PAPPAGIANIS D., SMITH C. E., BERMAN R. J., KOBAYASHI G. S. Experimental subcutaneous coccidioidal infection in the mouse. J Invest Dermatol. 1959 May;32(5):589–598. doi: 10.1038/jid.1959.98. [DOI] [PubMed] [Google Scholar]
  68. PAPPAGIANIS D., SMITH C. E., KOBAYASHI G. S. Relationship of the in vivo form of Coccidioides immitis to virulence. J Infect Dis. 1956 May-Jun;98(3):312–319. doi: 10.1093/infdis/98.3.312. [DOI] [PubMed] [Google Scholar]
  69. PAPPAGIANIS D., SMITH C. E., KOBAYASHI G. S., SAITO M. T. Studies of antigens from young mycelia of Coccidioides immitis. J Infect Dis. 1961 Jan-Feb;108:35–44. doi: 10.1093/infdis/108.1.35. [DOI] [PubMed] [Google Scholar]
  70. PERCEVAL A. K. EXPERIMENTAL CRYPTOCOCCOSIS: HYPERSENSITIVITY AND IMMUNITY. J Pathol Bacteriol. 1965 Apr;89:645–655. doi: 10.1002/path.1700890225. [DOI] [PubMed] [Google Scholar]
  71. PROCKNOW J. J., PAGE M. I., LOOSLI C. G. Early pathogenesis of experimental histoplasmosis. Arch Pathol. 1960 Apr;69:413–426. [PubMed] [Google Scholar]
  72. RITTER R. C., LARSH H. W. THE INFECTION OF WHITE MICE FOLLOWING AN INTRANASAL INSTILLATION OF CRYPTOCOCCUS NEOFORMANS. Am J Hyg. 1963 Sep;78:241–246. doi: 10.1093/oxfordjournals.aje.a120342. [DOI] [PubMed] [Google Scholar]
  73. ROWLEY D. A., HUBER M. Growth of Histoplasma capsulatum in normal, superinfected, and immunized mice. J Immunol. 1956 Jul;77(1):15–23. [PubMed] [Google Scholar]
  74. Ribi E., Larson C., Wicht W., List R., Goode G. Effective nonliving vaccine against experimental tuberculosis in mice. J Bacteriol. 1966 Mar;91(3):975–983. doi: 10.1128/jb.91.3.975-983.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. SALVIN S. B., BELL E. J. Resistance of mice with experimental histoplasmosis to infection with Rickettsia typhi. J Immunol. 1955 Jul;75(1):57–62. [PubMed] [Google Scholar]
  76. SALVIN S. B. Further studies on immunization of mice against Histoplasma capsulatum. Am J Hyg. 1955 Jan;61(1):72–81. doi: 10.1093/oxfordjournals.aje.a119741. [DOI] [PubMed] [Google Scholar]
  77. SALVIN S. B. Hypersensitivity in mice with experimental histoplasmosis. J Immunol. 1955 Jul;75(1):1–6. [PubMed] [Google Scholar]
  78. SALVIN S. B. Immunization of mice against Histoplasma capsulatum. J Immunol. 1953 Mar;70(3):267–270. [PubMed] [Google Scholar]
  79. SALVIN S. B. Immunologic aspects of the mycoses. Prog Allergy. 1963;7:213–331. doi: 10.1159/000391342. [DOI] [PubMed] [Google Scholar]
  80. SALVIN S. B., RIBI E. Antigens from yeast phase of Histoplasma capsulatum. II. Immunologic properties of protoplasm vs. cell walls. Proc Soc Exp Biol Med. 1955 Oct;90(1):287–294. doi: 10.3181/00379727-90-22012. [DOI] [PubMed] [Google Scholar]
  81. SALVIN S. B. Resistance to reinfection in experimental histoplasmosis. J Immunol. 1955 Mar;74(3):214–221. [PubMed] [Google Scholar]
  82. SALVIN S. B., SMITH R. F. An antigen for detection of hypersensitivity to Cryptococcus neoformans. Proc Soc Exp Biol Med. 1961 Nov;108:498–501. doi: 10.3181/00379727-108-26977. [DOI] [PubMed] [Google Scholar]
  83. SALVIN S. B., SMITH R. F. Antigens from the yeast phase of Histoplasma capsulatum. III. Isolation, properties, and activity of a protein-carbohydrate complex. J Infect Dis. 1959 Jul-Aug;105(1):45–53. doi: 10.1093/infdis/105.1.45. [DOI] [PubMed] [Google Scholar]
  84. SALVIN S. B. The influence of leucocytes from sensitized mice on resistance to Histoplasma capsulatum. Am J Hyg. 1958 Nov;68(3):233–241. doi: 10.1093/oxfordjournals.aje.a119965. [DOI] [PubMed] [Google Scholar]
  85. SASLAW S., CARLISE H. N., SPARKS J. Experimental histoplasmosis in monkeys. Proc Soc Exp Biol Med. 1960 Feb;103:342–344. doi: 10.3181/00379727-103-25512. [DOI] [PubMed] [Google Scholar]
  86. SASLAW S., SCHAEFER J. Relation of sex and aged to resistance of mice to experimental histoplasma infections. Proc Soc Exp Biol Med. 1955 Nov;90(2):400–402. doi: 10.3181/00379727-90-22046. [DOI] [PubMed] [Google Scholar]
  87. SASLAW S., SCHAEFER J. Survival of Histoplasma capsulatum in experimental histoplasmosis in mice. Proc Soc Exp Biol Med. 1956 Mar;91(3):412–414. doi: 10.3181/00379727-91-22279. [DOI] [PubMed] [Google Scholar]
  88. SCHAEFER J., SASLAW S. Some factors affecting resistance of mice to experimental histoplasmosis. Proc Soc Exp Biol Med. 1954 Feb;85(2):223–225. doi: 10.3181/00379727-85-20837. [DOI] [PubMed] [Google Scholar]
  89. SETHI K., SALFELDER K., SCHWARZ J. CROSS REACTIONS TO BLASTOMYCES DERMATITIDIS IN MICE. Mycopathol Mycol Appl. 1964 Nov 30;24:70–72. doi: 10.1007/BF02049437. [DOI] [PubMed] [Google Scholar]
  90. SINSKI J. T., LOWE E. P., CONANT N. F., HARDIN H. F., CASTLEBERRY M. W., RAY J. G., Jr IMMUNIZATION AGAINST EXPERIMENTAL LETHAL SIMIAN COCCIDIOIDOMYCOSIS USING WHOLE KILLED ARTHROSPORES AND CELL FRACTION. Mycologia. 1965 May-Jun;57:431–441. [PubMed] [Google Scholar]
  91. SMITH C. E., PAPPAGIANIS D., LEVINE H. B., SAITO M. Human coccidioidomycosis. Bacteriol Rev. 1961 Sep;25:310–320. doi: 10.1128/br.25.3.310-320.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Salfelder K., Schwarz J. Cross reactions to Histoplasma capsulatum in mice. Sabouraudia. 1964 Feb;3(2):164–166. [PubMed] [Google Scholar]
  93. Salvin S. B. Constituents of the cell wall of the yeast phase of Histoplasma capsulatum. Am Rev Respir Dis. 1965 Dec;92(6):119–125. doi: 10.1164/arrd.1965.92.6P2.119. [DOI] [PubMed] [Google Scholar]
  94. Sinski J. T. Coccidioidin sensitivity in control, immunized and infected guinea pigs. Mycopathol Mycol Appl. 1965 Dec 1;27(3):369–378. doi: 10.1007/BF02053795. [DOI] [PubMed] [Google Scholar]
  95. Sinski J. T., Lowe E. P., Castleberry M. W., Maire L. F., 3rd, Del Favero J. E., Pakes S. P., Converse J. L. Comparison of serologic reactions in experimental canine and simian coccidioidomycosis. Sabouraudia. 1963 Oct;3(1):106–113. doi: 10.1080/00362176485190151. [DOI] [PubMed] [Google Scholar]
  96. VOGEL R. A., CONANT N. F. Coccidioides immitis spherule antigen in a complement fixation test for experimental coccidioidomycosis. Proc Soc Exp Biol Med. 1952 Mar;79(3):544–547. doi: 10.3181/00379727-79-19440. [DOI] [PubMed] [Google Scholar]
  97. VOGEL R. A., FETTER B. F., CONANT N. F., LOWE E. P. Preliminary studies on artificial active immunization of guinea pigs against respiratory challenge with Coccidioides immitis. Am Rev Tuberc. 1954 Sep;70(3):498–503. doi: 10.1164/art.1954.70.3.498. [DOI] [PubMed] [Google Scholar]
  98. WALLRAFF E. B., SNOW I. B. COCCIDIOIDIN SKIN REACTIONS. J Immunol. 1964 Oct;93:625–628. [PubMed] [Google Scholar]
  99. WU W. G., MARCUS S. HUMORAL FACTORS IN CELLULAR RESISTANCE. I. THE EFFECTS OF HEATED AND UNHEATED HOMOLOGOUS AND HETEROLOGOUS SERA ON PHAGOCYTOSIS AND CYTOPEPSIS BY NORMAL AND "IMMUNE" MACROPHAGES. J Immunol. 1963 Sep;91:313–322. [PubMed] [Google Scholar]

Articles from Bacteriological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES